跳至主要内容
临床试验/DRKS00025099
DRKS00025099尚未招募不适用

Choices of therapeutic strategies for hepatocellular carcinoma (HCC)

Chirurgische Klinik, Universitätsmedizin Mannheim0 个研究点目标入组 200 人开始时间: 2021年4月22日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • All specialists at surgical, internal medicine and radiation therapy departments involved in the treatment of liver cancer patients are eligible to take part in the survey.

排除标准

  • Participants did not completely answer the survey.

研究者

发起方
Chirurgische Klinik, Universitätsmedizin Mannheim

相似试验

进行中(未招募)
不适用
Behandlung des fortgeschrittenen hepatozellulären Karzinoms mit dem mTOR-Inhibitor Rapamycin (HCC-Rap-001)Treatment of advanced hepatocellular carcinoma with the mTOR-inhibitor rapamycin (HCC-Rap-001) - treatment of HCC with rapamyciAdvanced hepatocellular carcinoma (HCC)
EUCTR2004-002834-20-ATniversitätsklinik für Innere Medizin IV, Klinische Abteilung Gastroenterologie und Hepatologie30
尚未招募
Unknown
Systemic therapy for Unresectable Hepatocellular Carcinoma: Therapeutic Effectiveness by Treatment Modality and Optimal Drug Use Ordernresectable hepatocellular carcinoma
JPRN-UMIN000051797Japanese Red Cross Society Himeji Hospital5,000
进行中(未招募)
不适用
Treatment of advanced hepatocellular carcinoma (HCC) with portal vein thrombosis by hepatic intra-arterial injection of microspheres loaded with Yttrium-90 (Thera-Sphere) - RAD-09advanced hepatocellular carcinoma (HCC) with portal vein thrombosisMedDRA version: 9.1Level: LLTClassification code 10024662MedDRA version: 9.1Level: PTClassification code 10019713
EUCTR2009-016475-29-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
招募中
不适用
Sequential therapy for hepatocellular carcinoma -Real world evidence of TKI in prospective observational studyhepatocellular carcinoma
JPRN-UMIN000038867Kyushu Study group of Clinical Cancer500
已完成
2 期
Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma
NCT02513199Icahn School of Medicine at Mount Sinai32
Choices of therapeutic strategies for hepatocellular... | 临床试验